Haemoctin SDH Dosage & Drug Information

Indications/Uses

Prophylaxis & treatment of bleeding in congenital &/or acquired factor VIII deficiency in haemophilia A.

Dosage/Direction for Use

Dosage is individualized based on the severity of factor VIII deficiency, location & extent of bleeding & patient's clinical condition. Early haemarthrosis, muscle or oral bleeding 20-40% 12-24 hrly for at least 1 day. More extensive haemarthrosis, muscle bleeding or haematoma 30-60% 12-24 hrly for 3-4 days. Life threatening haemorrhages 60-100% 8-24 hrly. Minor surgery including tooth extraction 30-60% 24 hrly for at least 1 day. Major surgery (pre- & postop) 8-24 hrly. Then, repeat therapy for at least 7 days to maintain 30-60% factor VIII activity.

Contraindications

Pregnancy & lactation.

Special Precautions

Regular monitoring of Ab formation. Consider hepatitis A & B vaccination.

Adverse Reactions

Rarely, hypersensitivity or allergic reactions, headache, hives, drop in BP, lethargy, nausea, restlessness, accelerated pulse, chest tightness, tingling, vomiting, wheezing, anaphylaxis, fever.

View ADR Reporting Link

MIMS Class

Haemostatics

ATC Classification

B02BD02 - coagulation factor VIII ; Belongs to the class of blood coagulation factors. Used in the treatment of hemorrhage.

Regulatory Classification

P₁S₁S₃

Presentation/Packing

Form

Haemoctin SDH 1000 IU powd for inj

Packing/Price

1's

Form

Haemoctin SDH 250 IU powd for inj

Packing/Price

1's

Form

Haemoctin SDH 500 IU powd for inj

Packing/Price

1's

Haemoctin SDH

factor viii

Manufacturer:

Biotest

Distributor:

Four Star

Chong Lap